The new product is a ready-to-use, injectable bone matrix in paste form, consisting of 100 percent synthetic, non-particular, phase-pure hydroxylapatite. It can be used during orthopedic, trauma and neurosurgery procedures to fill and reconstruct bone defects or in conjunction with allograft and autograft as bone graft extender.
More Articles on Orthopedic Devices:
FDA Sends Warning Letters to California Orthopedic & Spine Device Companies
FDA Publishes Guidance for Pre-market Approvals
Wright Medical Group Names James Lightman Senior Vice President
German Device Company Receives License for Orthopedic & Spine Injectable Bone MatrixWritten by Laura Miller | March 30, 2012
German medical device company aap Implantate has licensed one of its proprietary injectable bone matrix products for use during orthopedic and spine procedures.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.